Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07131683 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

hUC-MSC-Exo Therapy for Autoimmune Encephalitis

Study acronym: MESAE
StatusNot Yet Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a phase I/IIa study to investigate the safety and preliminary efficacy of intranasal admnistration of human umbilical mesenchymal stem cell-derived exosome (hUC-MSC-Exo) for patients with autoimmune encephalitis.
Trial Details
NCT Number NCT07131683
Lead Sponsor Xuanwu Hospital, Beijing
Collaborators: ECHO Biotech
Conditions
(from sponsor)		 Autoimmune Encephalitis
Related terms Autoimmune Diseases of the Nervous System
Enrollment 38 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov